The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Iovance Biotherapeutics, Inc(NASDAQ:IOVA) 
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead pro...
Website: http://www.iovance.com
Founded: 2007
Full Time Employees: 148
Sector: Healthcare
Industry: Biotechnology
Iovance Biotherapeutics Days Payable Outstanding ttm (DPO)
Iovance Biotherapeutics Days Receivable Outstanding ttm (DSO)
Iovance Biotherapeutics Days Inventory Outstanding ttm (DIO)
Iovance Biotherapeutics Op Cashflow Per Share ttm
Iovance Biotherapeutics Free Cashflow Per Share ttm
Iovance Biotherapeutics Cash Per Share ttm
Iovance Biotherapeutics P/S ratio ttm
Iovance Biotherapeutics (GAAP) P/E ratio ttm
Iovance Biotherapeutics P/B ratio ttm
No extra charts and metrics for this ticker.